Related Experiment Video
Updated: Mar 28, 2026

12:00
Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles
Published on: January 22, 2015
13.1K
Chitosan-based hydrogel nanoparticle amazing behaviors during transmission electron microscopy
1Pharmaceutical Sciences Research Center, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Pharmaceutics, School of Pharmacy, International branch, Shiraz University of Medical Sciences, Shiraz, Iran.
International Journal of Biological Macromolecules
|December 15, 2015
Summary
Researchers developed methotrexate-loaded nanogels for targeted drug delivery. The nanogel
Area of Science:
- Biomedical Engineering
- Materials Science
- Drug Delivery Systems
Background:
- Nanogels are promising polymeric nanoparticles for drug delivery and targeting.
- Developing effective carriers for brain-specific delivery of hydrophilic drugs across the blood-brain barrier (BBB) remains a challenge.
Purpose of the Study:
- To prepare and characterize a nanogel as a carrier for enhancing brain delivery of BBB-restricted hydrophilic drugs.
- To investigate the drug release kinetics of methotrexate-loaded nanogels.
Main Methods:
- Preparation of nanogels loaded with methotrexate using an ionic gelation process.
- Transmission electron microscopy (TEM) for visualizing nanogel structure and vacuole behavior.
- Analysis of drug release kinetics to correlate with nanogel structural changes.
Main Results:
- Hydrogel nanoparticles exhibited a polymeric matrix with aqueous vacuoles.
- TEM imaging revealed vacuole interconnection and dynamic volume changes upon electron exposure.
- Observed nanogel behavior correlated well with the drug release kinetic findings.
Conclusions:
- The study successfully prepared nanogels for potential enhanced drug delivery.
- The dynamic structural changes observed in nanogels provide insights into drug release mechanisms.
- Findings offer guidelines for designing hydrogel nanoparticles with predictable drug release for improved therapeutic efficacy.

